Literature DB >> 8603772

Ontogeny and tissue distribution of human GAD expression.

M I Mally1, V Cirulli, T Otonkoski, G Soto, A Hayek.   

Abstract

One of the major beta-cell autoantigens associated with IDDM is GAD. Although GAD expression has been detected in adult islets, transcriptional expression of the GAD genes has not been reported during human pancreatic ontogeny. We therefore analyzed patterns of GAD gene transcription by quantitating the mRNAs encoding both the 65- and 67-kDa isoforms (GAD65 and GAD67, respectively) in human fetal, postnatal, and adult pancreases, as well as in isolated adult islets, and examined their tissue-specific expression. Significant levels of pancreatic GAD65 transcripts were already detected at 13 weeks of gestation and were expressed at higher levels in the fetal and infantile pancreas than in the adult pancreas. Isolated adult pancreatic islets were highly enriched in GAD65 mRNA. In contrast, GAD67 transcripts were not detectable in fetal and postnatal pancreases. In addition to the pancreas, marked GAD expression was detected in the brain, whereas other tissues examined contained either low or undetectable GAD transcripts. Triple immunofluorescent staining of fetal and adult pancreases revealed colocalization of GAD65 with alpha- and beta-cells. In the fetal pancreas, strong immunoreactivity for GAD65 was also evident in epithelial cells, which lacked expression of insulin or glucagon, some of which were present in the ductal epithelium, suggesting that GAD65 expression might correlate with endocrine determination. In summary, 1) this is the first demonstration of GAD65 expression in the human fetal pancreas, implicating a potential role during islet development, and 2) GAD65 may be a useful marker for the identification of primitive islet cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603772     DOI: 10.2337/diab.45.4.496

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

Review 1.  Mechanistic basis of immunotherapies for type 1 diabetes mellitus.

Authors:  Wenhao Chen; Aini Xie; Lawrence Chan
Journal:  Transl Res       Date:  2013-01-22       Impact factor: 7.012

Review 2.  Islet Autoantibodies.

Authors:  Vito Lampasona; Daniela Liberati
Journal:  Curr Diab Rep       Date:  2016-06       Impact factor: 4.810

Review 3.  Autoreactive T cells in type 1 diabetes.

Authors:  Alberto Pugliese
Journal:  J Clin Invest       Date:  2017-08-01       Impact factor: 14.808

4.  Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome.

Authors:  Gucci Jijuan Gu Urban; Mikaela Friedman; Ping Ren; Carina Törn; Malin Fex; Christiane S Hampe; Åke Lernmark; Ulf Landegren; Masood Kamali-Moghaddam
Journal:  Sci Rep       Date:  2015-06-16       Impact factor: 4.379

5.  Expression of GAD67 and novel GAD67 splice variants during human fetal pancreas development: GAD67 expression in the fetal pancreas.

Authors:  Esther Korpershoek; Aart M Verwest; Ynske Ijzendoorn; Robbert Rottier; Hemmo A Drexhage; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

6.  Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.

Authors:  Francesco Vendrame; Antonello Pileggi; Elsa Laughlin; Gloria Allende; Ainhoa Martin-Pagola; R Damaris Molano; Stavros Diamantopoulos; Nathan Standifer; Kelly Geubtner; Ben A Falk; Hirohito Ichii; Hidenori Takahashi; Isaac Snowhite; Zhibin Chen; Armando Mendez; Linda Chen; Junichiro Sageshima; Phillip Ruiz; Gaetano Ciancio; Camillo Ricordi; Helena Reijonen; Gerald T Nepom; George W Burke; Alberto Pugliese
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

Review 7.  Biomarkers in Islet Cell Transplantation for Type 1 Diabetes.

Authors:  Fatimah T AlRashidi; Kathleen M Gillespie
Journal:  Curr Diab Rep       Date:  2018-09-05       Impact factor: 4.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.